Arkolith/Insider Trading/AXDX/Form 4

Patience David

Chief Financial OfficerAccelerate Diagnostics, Inc (AXDX) · full profile →Form 4 · filed Apr 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2025Sell(S)7K$0.71$5K65K
Apr 1, 2025Option exercise(M)20K—$071K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2025Option exercise(M)20K—$030K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-031298) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML